New $37 Million Heart Valve Manufacturing Facility Expected to Create 500 Jobs

Health care technology giant Abbott plans to establish a new $37.6 million heart valve manufacturing facility in suburban Indianapolis, local officials announced Tuesday.

The project in Westfield, Indiana, is slated to be conducted in two phases over the next five years. Over that span, the complex is expected to create 477 new jobs.

“This facility will help in our goal to improve the health of people around the world and meet the needs of physicians and patients battling structural heart disease,” Abbott’s Mike Dale said in a statement.

The facility will produce Abbott’s MitraClip transcatheter mitral valve repair system, which allows a small, clip-based device to repair mitral regurgitation without open-heart surgery. The MitraClip, which will continue to be produced in California along with the new Indiana operation, has been implanted in more than 90,000 patients worldwide, officials said.

Construction will begin this year, and the facility will open in 2021. The project will wrap up by the end of 2024.

Indiana’s economic development agency offered more than $5.2 million in tax benefits, training grants, and infrastructure improvements to support the project. Abbott is also expected to receive abatements from the city of Westfield and cost offsets from Duke Energy.